For the first time, a pharmacotherapy for overweight and obesity has reduced cardiovascular events in patients with established cardiovascular disease in the absence of type 2 diabetes.
Read MoreMenopausal Hormone Therapy and Heart Risk: Updated Guidance Is at Hand
A new review by an American College of Cardiology working group urges a nuanced approach in counseling women about the benefits and risks of hormone therapy from a cardiology perspective.
New Weight-Loss Drugs Are Poised to Upend Preventive Cardiology Care in Patients With Obesity and Overweight
Randomized trial evidence that weight loss can yield cardiovascular benefits independent of antidiabetic effects has been elusive. Two major ongoing trials are likely to change that, with potentially big implications for clinical practice.
Statins Reduce Circulating TMAO, Suggesting Another Way They Curb Cardiovascular Risk
A new study suggests that plasma levels of this gut microbial metabolite might help further stratify cardiovascular risk when characterizing patients’ response to statin therapy.
Dietary Supplements Don’t Stack Up to Low-Dose Statin Therapy for LDL-C Reduction
Despite marketing claims, none of six dietary supplements commonly used for lipid lowering significantly reduced LDL cholesterol versus placebo adults with elevated atherosclerotic risk, a new study finds.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Study Sheds Light on Red Meat’s Contribution to Atherosclerosis Risk in Older Adults
A large cohort study found that higher meat consumption was associated with incident atherosclerotic cardiovascular disease, with the linkage mediated in part by microbiota-derived metabolites of L-carnitine.
Bariatric Surgery for Obesity at Age 65 and Beyond: A Cardiovascular Win
A large Medicare database analysis provides some of the best evidence to date that bariatric surgery’s cardiovascular benefits extend even to patients aged 65 or older.
Novel siRNA Therapy Lowers Elevated Plasma Lipoprotein(a) in Phase 1 APOLLO Trial
The short interfering RNA compound SLN360 produced robust and sustained Lp(a) reductions with good tolerability, setting the stage for further studies to address this elusive cardiovascular risk factor.
Dietary Nitrate Exerts Differing Platelet Effects in Men and Women
Dietary nitrate — found in green leafy vegetables and other healthy foods — appears to inhibit platelet activation in women while increasing it in men, suggests a hypothesis-generating study.
The Obesity Paradox in Heart Failure: How to Advise Patients on the Role of Cardiorespiratory Fitness?
Cardiorespiratory fitness is a major factor influencing the obesity paradox in heart failure. Our experts reviewed the available evidence to guide patient counseling on an evolving issue.
Draft USPSTF Guidance Brings Welcome Change in Advice on Aspirin for Primary Cardiac Prevention
The federal task force’s revised recommendations put it in step with most other guidelines — and with the preponderance of recent evidence.